GSK plc (GSK)
$47.87+3.46%Close
SELLRECOVERY · day 22
Key stats
Short interest · FINRA settlement 2026-09-30
52-week IV4.7%–67.7%
- Market cap
- $96.6B
- Beta
- 0.28
- Div yield
- 3.79%
- P/E (TTM)
- 15.13
- IV-%ile
- 90
- IV ATM
- 39.3%
- Short % float
- 0.76%
- Days to cover
- 4.1
- SI change
- +1.0%
- 1W
- +1.81%
- 1M
- -4.28%
- vs SPY 1W
- +2.79%
- vs SPY 1M
- -6.14%
Industry peers
FMP comparable companies · ranked by market cap
- LLYBUYEli Lilly and Company$1.1TRECOVERYQ 21$1179.27+3.62%
- JNJSELLJohnson & Johnson$630.0BBEARQ 22$261.44+2.13%
- MRKSELLMerck & Co., Inc.$359.6BBEARQ 11$145.60+3.80%
- RHHBYRoche Holding AG$344.8B$54.09
- NVSBUYNovartis AG$273.2BRECOVERYQ 20$143.75+3.14%
- AZNSELLAstraZeneca PLC$246.9BRECOVERYQ 20$159.20+3.99%
- AMGNBUYAmgen Inc.$223.9BRECOVERYQ 22$414.87+3.21%
- NVOSELLNovo Nordisk A/S$171.6BRECOVERYQ 20$38.64+0.16%
- PFEBUYPfizer Inc.$161.2BBULLQ 13$28.28+2.96%
- SNYSELLSanofi$96.2BBEARQ 11$40.07+1.66%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on GSK?
- LOPJLB’s latest quantitative signal on GSK plc (GSK) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is GSK in?
- GSK plc (GSK) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does GSK plc (GSK) do?
- GSK plc, a global pharmaceutical entity founded in 1715 and headquartered in Brentford, United Kingdom, dedicates its efforts to the research, development, and manufacturing of a wide array of medical solutions. Until May 2022, the company was known as GlaxoSmithKline plc. Its primary objective is to prevent and treat illnesses by producing both vaccines and a comprehensive range of specialty a…